The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev ... about any other medications or supplements they’re taking.

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Parkinson’s disease is a chronic and progressive condition affecting the brain and nervous system. It impacts millions of ...

Although brain-implanted electrodes do help minimize the effects of Parkinson's disease and other neurological disorders, implanting and activating those electrodes can be a tricky process.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

Broadcaster John Stapleton has urged others to seek help if they have “doubts” about their health after revealing his Parkinson’s disease diagnosis. The 78-year-old, who presented on ...

Parkinson's disease and attention deficit hyperactivity disorder (ADHD) may be genetically linked, with effects on brain volume, a large study has found. "There is strong evidence that ADHD and ...

On average, they survive for only two to five years after being diagnosed, according to the Centers for Disease Control and Prevention. Scientists at Northwestern and Case Western Reserve ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...